Financial services provider Silver Falcon plans to acquire biotechnology company Hemogenyx Pharmaceuticals (Hemogenyx Pharma) for £8m ($10.5m).

The transaction will enable the acquirer company to expand its business operations.

Both the acquirer and target companies are based in the UK.

Adcock Ingram Holdings has announced its 100% acquisition of Genop Holdings, a subsidiary of healthcare service provider Genop Healthcare.

The transaction complements the acquirer company’s existing portfolio.

“Adcock Ingram Holdings has announced its 100% acquisition of Genop Holdings, a subsidiary of healthcare service provider Genop Healthcare.”

Both companies involved in the acquisition are based in South Africa.

How well do you really know your competitors?

Access the most comprehensive Company Profiles on the market, powered by GlobalData. Save hours of research. Gain competitive edge.

Company Profile – free sample

Thank you!

Your download email will arrive shortly

Not ready to buy yet? Download a free sample

We are confident about the unique quality of our Company Profiles. However, we want you to make the most beneficial decision for your business, so we offer a free sample that you can download by submitting the below form

By GlobalData
Visit our Privacy Policy for more information about our services, how we may use, process and share your personal data, including information of your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Our services are intended for corporate subscribers and you warrant that the email address submitted is your corporate email address.

Chinese biopharmaceutical products provider Boya Bio-pharmaceutical Group (formerly Jiangxi Boya Bio-Pharmaceutical), plans to acquire 82% stake in an undisclosed Chinese pharmaceutical company.

Financial services provider China Huarong Asset Management (formerly China Huarong Asset Management), has announced the sale of eight million shares representing 1.73% stake in pharmaceutical company Northeast Pharmaceutical Group.

Both companies involved in the transaction are based in China.